Claret Bioscience LLC
Integrated DNA and RNA NGS library preparation protocol using single-strand ligation for simultaneous multiomic sequencing from limited samples
- Sector
- Biotech
- Headquarters
- Birmingham, MI
- Total capital
- $1.7M
- Federal grants
- $1.7M
- 6 awards · 2018–2024
- Rank in peer group#229 of 502
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $5K
- 1 award · Smithsonian Instit
- Rank in Biotech#389 of 4373
- Granted patents
- 1
- 39 pending · first 2023
- Rank in peer group#57 of 502
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · A rapid method for global and targeted miRNA next generation sequencing$359K
- Federal contractSmithsonian Instit · Dna Extraction Supplies For Barcode Of Life$5K
- Federal grantHealth and Human S · Phase I · A single-strand ligation approach for concomitant DNA and RNA next-generation sequencing from low abundance inputs$224K
- Federal grantHealth and Human S · Phase I · A single-strand ligation approach for concomitant DNA and RNA next-generation sequencing from low abundance inputs$224K
- Federal grantHealth and Human S · Phase I · A fast, scalable, cost-effective, single-stranded library protocol for cell-free DNA$300K
- Federal grantHealth and Human S · Phase I · Exploiting signals of cell-free DNA degradation for clinical research and cancer diagnostics$299K
- Federal grantHealth and Human S · Phase I · Exploiting signals of cell-free DNA degradation for clinical research and cancer diagnostics$299K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grants#229 · top 46%
- Granted patents#57 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 40- PendingMethods And Compositions For Analyzing Nucleic AcidUSPTOApplication 18837787
- PendingMethods And Compositions For Analyzing Nucleic AcidUSPTOApplication 18029550
- PendingMethods And Compositions For Analyzing Nucleic AcidUSPTOApplication 18280588
Show all 40 patent records
- Methods And Compositions For Analyzing Nucleic AcidJan 16, 2025 · Application 18837787Pending
- Methods And Compositions For Analyzing Nucleic AcidNov 28, 2024 · Application 18029550Pending
- Methods And Compositions For Analyzing Nucleic AcidMay 9, 2024 · Application 18280588Pending
- Methods And Compositions For Analyzing Nucleic AcidDec 7, 2023 · Application 18096192Pending
- Cancer Detection, Monitoring, And Reporting From Sequencing Cell-free DnaOct 26, 2023 · Application 18016957Pending
- Methods And Compositions For Analyzing Nucleic AcidJul 27, 2023 · Application 18011271Pending
- Methods And Compositions For Analyzing Nucleic AcidFeb 21, 2023 · US 11,584,929Granted
- Methods And Compositions For Analyzing Nucleic AcidJan 19, 2023 · Application 17766031Pending
- Methods And Compositions For Analyzing Nucleic AcidNov 3, 2022 · Application 17440386Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication PCTUS2022019255Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63311182Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63307511Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63277906Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication PCTUS2021053791Pending
- Cancer Detection, Monitoring, And Reporting From Sequencing Cell-free DnaApplication PCTUS2021042360Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication PCTUS2021038609Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63195352Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 19489226Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 19106916Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63161549Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63159174Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63158574Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63089191Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication PCTUS2020054722Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63086208Pending
- Cancer Detection, Monitoring, And Reporting From Sequencing Cell-free DnaApplication 63054671Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63043688Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication PCTUS2020026421Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 62938505Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 62925132Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 62913045Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 62861594Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 62830211Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication PCTUS2019013210Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 62769787Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 62618382Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication PCTUS2025021867Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 62617055Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication 63715333Pending
- Methods And Compositions For Analyzing Nucleic AcidApplication PCTUS2024032417Pending
Related companies, and why
- Zenobia Therapeutics, Inc.Similar federal contract value in Biotech · $8K in contracts
- RADIOMEDIX, INC.Similar federal contract value in Biotech · $5K in contracts
- STEALTH BIOLOGICS LLCSimilar federal contract value in Biotech · $5K in contracts
- Minerva NeurosciencesSimilar federal contract value in Biotech · $5K in contracts
- Foresite LabsSimilar federal contract value in Biotech · $3K in contracts
- Veloxis PharmaceuticalsSimilar federal contract value in Biotech · $83 in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .